Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced it is presenting its latest line of advanced wound care and medical coating products, including ColActive® Plus Ag from August 10th to 12th at FIME International Medical Expo, the largest international medical trade fair and congress in the United States for conventional medical distributor networks, group purchasing organizations, integrated delivery networks, hospitals, imaging centers, private practice facilities, and home and durable medical equipment providers seeking the latest medical products from all over the world.
Since recovering the exclusive worldwide rights to its ColActive® brand and other advanced wound care products, Covalon has introduced ColActive® Plus Ag, a patented collagen matrix wound dressing which is available for distribution and is cleared for regulatory purposes in the United States, Canada and other jurisdictions. Covalon is also showcasing clear film antimicrobial surgical wound and IV securement dressings, along with lubricious and antimicrobial coated catheters which are available for distribution in North America and international markets.
"We are excited about showcasing our latest line of innovative, market-ready wound care and coating products to distributors and hospital buying groups," stated Brian Pedlar, Covalon's Chief Executive Officer. "Our attendance at FIME International Medical Expo in Miami Beach is another step in Covalon's expansion into new distribution markets and we look forward to developing further relationships at the show."
Study identifies RNA molecule crucial for skin wound healing